Treatment and Management of Xanthinuria
At a Glance
Managing hereditary xanthinuria focuses on preventing kidney stones through extreme hydration and a low-purine diet. Patients with Type II xanthinuria must also strictly avoid certain medications, like thiopurines and methotrexate, which can reach toxic levels due to a missing enzyme.
Managing hereditary xanthinuria is focused on one primary goal: preventing the formation of xanthine stones in the kidneys [1][2]. Because this condition is so rare, there are no formal standard of care guidelines like there are for diabetes or heart disease. Instead, management is tailored to your specific lab values and symptoms [3][4].
The Core Pillars of Management
For most patients, the strategy is defensive—preventing crystals from forming rather than treating them after they appear.
- Hyperhydration (High Fluid Intake): This is the most critical step [3]. By drinking large amounts of water, you dilute your urine so that xanthine cannot reach high enough concentrations to form crystals [5]. You may be advised to drink enough to produce 2 to 3 liters of urine per day, which often means drinking water throughout the night as well.
- Low-Purine Diet: Since xanthine comes from the breakdown of purines, reducing purines in your diet can lower the raw material that turns into stones [6]. While you should work with a specialized dietitian, a low-purine approach typically involves:
- Avoiding: Organ meats (liver, kidneys), high-purine seafood (sardines, anchovies, shellfish), and foods with high-fructose corn syrup.
- Limiting: Red meat and alcohol.
- Encouraging: Hydrating foods, vegetables, and complex carbohydrates.
- Urine Alkalinization: While less effective for xanthine than for uric acid, some doctors may use medications like potassium citrate to make the urine less acidic, which may help keep crystals from sticking together [7][8].
A Warning About Standard Stone Medications
Because xanthinuria is incredibly rare, doctors who are unfamiliar with it might see a history of kidney stones and reflexively consider prescribing allopurinol [9]. Allopurinol is a common drug used to treat gout and certain kidney stones. However, it works by shutting down the XDH enzyme—the exact enzyme you are already missing [10].
For someone with hereditary xanthinuria, allopurinol is ineffective and unnecessary. It is crucial to inform any new urologist or nephrologist of your exact diagnosis so they do not prescribe standard gout or stone medications by mistake.
Critical Warning: Medication Safety in Type II
If you have Type II xanthinuria, you lack the enzyme Aldehyde Oxidase (AO) [5]. This enzyme is responsible for clearing several common medications from your body. Without it, these drugs can build up to toxic levels [11][12].
If you have Type II, use extreme caution and consult your specialist before taking:
- Thiopurines: Drugs like Azathioprine and 6-Mercaptopurine (used for autoimmune diseases or cancer) can become highly toxic and even fatal [13][12].
- Methotrexate: Used for rheumatoid arthritis and psoriasis; its clearance can be severely blocked [14][15].
- Certain Antivirals: Newer drugs like Favipiravir may interfere with this pathway [14].
- Sleep Medications: Drugs like Zaleplon are processed by AO [15].
Always inform every doctor, pharmacist, and surgeon you see that you have a combined enzyme deficiency involving Aldehyde Oxidase [12].
The Emerging Role of Theobromine
Recent research has highlighted a potential new tool for stone prevention: theobromine, a compound found naturally in cocoa [16].
- How it Works: Theobromine and its breakdown products, like 7-methylxanthine (7-MX), look very similar to xanthine [17]. Scientists believe they trick the stone-forming process by sitting in the spots where xanthine would normally crystallize, effectively slowing or stopping stone growth [17][18].
- Evidence: While large clinical trials are still needed, studies suggest that consuming theobromine-containing substances may protect against xanthine stone formation [16][19]. Discuss with your doctor whether incorporating theobromine is right for you.
Common questions in this guide
How much water should I drink if I have hereditary xanthinuria?
What foods should I avoid on a low-purine diet for xanthinuria?
Why should I avoid taking allopurinol if I have xanthinuria?
What medications are dangerous for people with Type II xanthinuria?
Can cocoa or theobromine help prevent xanthine kidney stones?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my stone risk, how many liters of water should I be drinking every day?
- 2.Am I taking any medications that are metabolized by Aldehyde Oxidase (AO), and do we need to find alternatives?
- 3.Should I consider taking theobromine or a 7-methylxanthine supplement to help prevent xanthine stones?
- 4.Can you refer me to a dietitian who specializes in low-purine diets for metabolic disorders?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Successful Kidney Transplantation in a Young Male with Type 2 Xanthinuria.
Kota M, Madarasu RC, Penmetsa VV, et al.
Indian journal of nephrology 2024; (34(4)):403-405 doi:10.25259/ijn_509_23.
PMID: 39156844 - 2
Hereditary xanthinuria in a goat.
Vail KJ, Tate NM, Likavec T, et al.
Journal of veterinary internal medicine 2019; (33(2)):1009-1014 doi:10.1111/jvim.15431.
PMID: 30758870 - 3
A frameshift mutation in MOCOS is associated with familial renal syndrome (xanthinuria) in Tyrolean Grey cattle.
Murgiano L, Jagannathan V, Piffer C, et al.
BMC veterinary research 2016; (12(1)):276 doi:10.1186/s12917-016-0904-4.
PMID: 27919260 - 4
Classical Xanthinuria in Nine Israeli Families and Two Isolated Cases from Germany: Molecular, Biochemical and Population Genetics Aspects.
Peretz H, Lagziel A, Bittner F, et al.
Biomedicines 2021; (9(7)) doi:10.3390/biomedicines9070788.
PMID: 34356852 - 5
A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase.
Iguchi A, Sato T, Yamazaki M, et al.
CEN case reports 2016; (5(2)):158-162 doi:10.1007/s13730-016-0216-3.
PMID: 28508967 - 6
Multiple variants in XDH and MOCOS underlie xanthine urolithiasis in dogs.
Tate NM, Minor KM, Lulich JP, et al.
Molecular genetics and metabolism reports 2021; (29()):100792 doi:10.1016/j.ymgmr.2021.100792.
PMID: 34584846 - 7
Pure xanthine pediatric urolithiasis: A cause of acute renal failure.
Umair M, Hussain SZ, Khan A, et al.
Urology case reports 2021; (34()):101438 doi:10.1016/j.eucr.2020.101438.
PMID: 33083235 - 8
Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine.
Hernandez Y, Costa-Bauza A, Calvó P, et al.
Nutrients 2020; (12(7)) doi:10.3390/nu12072012.
PMID: 32645831 - 9
Xanthinuria secondary to allopurinol treatment in dogs with leishmaniosis: Current perspectives of the Iberian veterinary community.
Jesus L, Arenas C, Domínguez-Ruiz M, et al.
Comparative immunology, microbiology and infectious diseases 2022; (83()):101783 doi:10.1016/j.cimid.2022.101783.
PMID: 35240487 - 10
Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
Segarra S, Miró G, Montoya A, et al.
Veterinary parasitology 2017; (239()):50-56 doi:10.1016/j.vetpar.2017.04.014.
PMID: 28495197 - 11
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II).
Stiburkova B, Pavelcova K, Petru L, Krijt J
Toxicology and applied pharmacology 2018; (353()):102-108 doi:10.1016/j.taap.2018.06.015.
PMID: 29935280 - 12
Clinical and genetic analysis of MOCOS gene-related hypouricemia.
Peng H, Tu P, Ma Q, et al.
Frontiers in genetics 2025; (16()):1636032 doi:10.3389/fgene.2025.1636032.
PMID: 41164817 - 13
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors.
Ueda H, Narumi K, Asano S, et al.
Expert opinion on drug safety 2024; (23(1)):89-97 doi:10.1080/14740338.2023.2295976.
PMID: 38097359 - 14
A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma.
Demir E, Sütcüoğlu O, Demir B, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022; (28(2)):445-448 doi:10.1177/10781552211031304.
PMID: 34255596 - 15
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK, Tan ARY, Sivanandam P, et al.
The Journal of pharmacology and experimental therapeutics 2020; (374(2)):295-307 doi:10.1124/jpet.120.265249.
PMID: 32393528 - 16
Xanthine urolithiasis: Inhibitors of xanthine crystallization.
Grases F, Costa-Bauza A, Roig J, Rodriguez A
PloS one 2018; (13(8)):e0198881 doi:10.1371/journal.pone.0198881.
PMID: 30157195 - 17
Theobromine for treatment of uric acid stones and other diseases.
Trinchieri A
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 2024; (96(4)):13277 doi:10.4081/aiua.2024.13277.
PMID: 39692405 - 18
Efficacy of Theobromine and Its Metabolites in Reducing the Risk of Uric Acid Lithiasis.
Costa-Bauzá A, Calvó P, Hernández Y, Grases F
International journal of molecular sciences 2023; (24(13)) doi:10.3390/ijms241310879.
PMID: 37446053 - 19
7-Methylxanthine Inhibits the Formation of Monosodium Urate Crystals by Increasing Its Solubility.
Costa-Bauza A, Grases F
Biomolecules 2023; (13(12)) doi:10.3390/biom13121769.
PMID: 38136640
This page provides general information on the management of hereditary xanthinuria for educational purposes. Always consult your nephrologist, urologist, or metabolic specialist before changing your diet, hydration plan, or taking new medications.
Get notified when new evidence is published on Hereditary xanthinuria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.